Abstract
In Japan, a number of serious public health crises involving environmental pollution, food-borne diseases, and health hazards due to pharmaceuticals (i.e., “Yakugai”) have occurred in the past 50 years. Based on the literature, we summarize the initial investigations and the subsequent measures. Some common points emerge: (1) prolonged cause identification, (2) lack of countermeasures after the cause was identified, and (3) discrimination against victims and they contributed to spreading the damage. We identify lack of corporate ethics and ill-timed disclosure of information as the principal problems in Japan's crisis-management systems. Defects in information gathering were common to all of the cases, thus we suggest necessary corrective measures, such as the establishment of a new reporting system for health hazard-related information.
Similar content being viewed by others
References
Nomiyama K . Recent progress and perspectives in cadmium health effects studies. Sci Total Environ. 1980;14:199–232.
Tsuchiya K . Health effects of cadmium with special reference to studies in Japan. IARC Sci Publ. 1992;118:35–49.
Nogawa K, Kido T . Biological monitoring of cadmium exposure in Itai-itai disease epidemiology. Int Arch Occup Environ Health. 1993;65 (1 Suppl):S43–S46.
Kazantzis G . Cadmium, osteoporosis and calcium metabolism. BioMetals. 2004;17:493–498.
Ogino N, Yoshioka K . Itai-itai byou no gen-in ni kansuru kenkyu ni tsuite [A study on the etiology of Itai-Itai disease]. Nippon Seikeigekagakkai zasshi [J Jpn Orthop Assoc]. 1961;35:812–815 (in Japanese).
McAlpine D, Araki S . Minamata disease: an unusual neurological disorder caused by contaminated fish. Lancet. 1958;2:629–631.
Igata A . Epidemiological and clinical features of Minamata disease. Environ Res. 1993;63:157–169.
Harada M . Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol. 1995;25:1–24.
Eto K . Pathology of Minamata disease. Toxicol Pathol. 1997;25:614–623.
Eto K . Minamata disease. Neuropathology. 2000;20 (Suppl):S14–S19.
Yoshida K, Oshima H, Imai M . Air pollution and asthma in Yokkaichi. Arch Environ Health. 1966;13:763–768.
Yoshida K, Takatsuka Y, Kitabatake M, Oshima H, Imai M . Air pollution and its health effects in Yokkaichi area. Review on Yokkaichi asthma. Mie Med J. 1969;18:195–209.
Kitagawa T . Cause analysis of the Yokkaichi asthma episode in Japan. J Air Pollut Control Assoc. 1984;34:743–746.
Imai M, Yoshida K, Kitabatake M . Mortality from asthma and chronic bronchitis associated with changes in sulfur oxides air pollution. Arch Environ Health. 1986;41:29–35.
Yamashita N, Doi M . Some consideration about registration of sufferers from poisoning by arsenic tainted Morinaga Dry Milk. Nippon Eiseigaku Zasshi [Jpn J Hygiene]. 1975;29:568–580 (in Japanese).
Yamashita N, Doi M, Nishio M, Hojo H, Tanaka M . Recent observations of Kyoto children poisoned by arsenic tainted “Morinaga Dry Milk”. Nippon Eiseigaku Zasshi [Jpn J Hygiene]. 1972;27:364–399 (in Japanese).
Yoshimura T . Yusho in Japan. Indust Health. 2003;41:139–148.
Kashimoto T, Miyata H, Kunita S, Tung TC, Hsu ST, Chang KJ, et al. Role of polychlorinated dibenzofuran in Yusho (PCB poisoning). Arch Environ Health. 1981;36:321–326.
Masuda Y, Yoshimura H . Chemical analysis and toxicity of polychlorinated biphenyls and dibenzofurans in relation to Yusho. J Toxicol Sci. 1982;7:161–175.
Masuda Y, Yoshimura H . Polychlorinated biphenyls and dibenzofurans in patients with Yusho and their toxicological significance: a review. Am J Indust Med. 1984;5:31–44.
Kuratsune M, Morikawa Y, Hirohata T, Nishizumi M, Seishi K, Yoshimura T, et al. An epidemiologic study on “Yusho” or chlorobiphenyls poisoning. Fukuoka Acta Medica. 1969;60:513–532.
Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A . Epidemiologic study of polychlorinated biphenyls. Environ Health Perspect. 1972;1:119–128.
Nakayama J, Matsuda Y, Kuratsune M . Determination of polychrorinated dibenzofurans in tissues of patients with Yusho. Fd Cosmet Toxicol. 1977;15:195–198.
Matsuda Y, Kagawa R, Kuroki H . Transfer of polychlorinated biphenyls from mothers to fetuses and infants. Fd Cosmet Toxicol. 1978;16:543–546.
Yukioka H, Kurita S . Escherichia coli O157 infection disaster in Japan, 1996. Eur J Emerg Med. 1997;4:165.
Takeda Y . Enterohaemorrhagic Escherichia coli. World Health Stat Q. 1997;50:74–80.
Mermin JH, Griffin PM . Public health in crisis: outbreaks of Escherichia coli O157:H7 infections in Japan. Am J Epidemiol. 1999;150:797–803.
Michino H, Araki K, Minami S, Takaya S, Sakai N, Miyazaki M, et al. Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol. 1999;150:787–796.
Swinbanks D . Japan shuns radishes after ‘possible link’ to E. coli. Nature. 1996;382:567.
Asao T, Kumeda Y, Kawai T, Shibata T, Oda H, Haruki K, et al. An extensive outbreak of staphylococcal food poisoning due to low-fat milk in Japan: estimation of enterotoxin A in the incriminated milk and powdered skim milk. Epidemiol Infect. 2003;130:33–40.
Yamashita K, Kanazawa Y, Ueno M, Ohta H, Kitaguchi M, Kawakami T, et al. Significance of the detection of staphylococcal enterotoxin A gene in low fat milk which caused a serious outbreak of food poisoning. J Food Hyg Soc Jpn. 2003;44:186–190 (in Japanese).
Yamane H . Outbreak of the food poisoning due to contaminated low fat milk in Japan and the preventive measures. J Food Hyg Soc Jpn. 2003;44:J281–J285 (in Japanese).
Ikeda T, Tamate N, Yamaguchi K, Makino S . Mass outbreak of food poisoning disease caused by small amounts of staphylococcal enterotoxins A and H. Appl Environ Microbiol. 2005;71:2793–2795.
Mellin GW, Katzenstein M . The saga of thalidomide: neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med. 1962;267:1184–1192.
Kelsey FO . Thalidomide update: regulatory aspects. Teratology. 1988;38:221–226.
Lenz W . A short history of thalidomide embryopathy. Teratology. 1988;38:203–215.
Kajii T, Shinohara M . Thalidomide in Japan. Lancet. 1963;281:501–502.
Kajii T . Thalidomide experience in Japan. Ann Paediatr [Int Rev Pediatr]. 1965;205:341–354.
Kajii T, Kida M, Takahashi K . The effect of thalidomide intake during 113 human pregnancies. Teratology. 1973;8:163–166.
Miyairi M, Imura O, Tamura T, Hoshikawa K, Chida A . A case of so-called “subacute-myelo-optico-neuropathy” (SMON) from which Coxsackie type A 4 was isolated. Nippon Naika Gakkai Zasshi [J Jpn Soc Int Med]. 1968;57:1113–1117.
Ota Z . Electron microscopic demonstration of a new virus isolated from a patient with SMON. Acta Med Okayama. 1970;24:573–577.
Inoue YK, Nishibe Y, Nakamura Y . Virus associated with S.M.O.N. in Japan. Lancet. 1971;297:853–854.
Tsubaki T, Honma Y, Hoshi M . Neurological syndrome associated with clioquinol. Lancet. 1971;297:696–697.
Nakae K, Yamamoto S, Igata A . Subacute myelo-optico-neuropathy (S.M.O.N.) in Japan. A community survey. Lancet. 1971;297:510–512.
Cavanagh JB . The aetiology of S.M.O.N. Lancet. 1971;297:868–869.
Nakae K, Yamamoto S, Shigematsu I, Kono R . Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey. Lancet. 1973;301:171–173.
Barker S, Swinbanks D . Health ministry accepts liability in Japanese HIV-infected blood row. Nature. 1996;379:663–664.
Swinbanks D . Documents confirm delays in Japanese HIV blood scandal. Nature. 1996;379:760.
Barker S . Courts back research and compensation for Japanese HIV victims. Nature. 1996;380:92.
Spurgeon D . Japan agrees to pay HIV-blood victims. Nature. 1996;380:278.
Swinbanks D . Japan's HIV blood scandal broadens out. Nature. 1996;383:291.
Guest R . Japan apologizes for HIV infected blood products. BMJ. 1996;312:461.
Nathan R . Guilty pleas intensify row over contaminated blood. Nat Med. 1997;3:480–481.
Saegusa A . Japanese officials were aware of HIV in blood products. Nat Med. 1998;4:991.
Watts J . Tainted-blood revelation shocks Japanese. Lancet. 1998;352:554.
Cullinane J . Tainted blood and vengeful spirits: the legacy of Japan's Yakugai-AIDS trial. Culture, Med Psychiatry. 2005;29:5–31.
Seki Y, Yamazaki Y, Inoue Y, Wakabayashi C, Seto S . How HIV infected hemophiliacs in Japan were informed of their HIV-positive status. AIDS Care. 2002;14:651–664.
Egilman D, Scout . Corporate corruption of science--the case of chromium(VI). Int J Occup Environ Health. 2006;12:169–176.
Bradley CA, Rolka H, Walker D, Loonsk J . BioSense: implementation of a National Early Event Detection and Situational Awareness System. MMWR – Morb Mortal Wkly Rep. 2005;54 (Suppl):11–19.
Reyes M, Gary Jr HE, Dobbins JG, Randall B, Steele L, Fukuda K, et al. Surveillance for chronic fatigue syndrome – four US cities, September 1989 through August 1993. MMWR – Morb Mortal Wkly Rep. 1997;46:1–13.
Fischer H, Konig P, Dierich MP, Allerberger F . Hemolytic-uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157 and non-O157 enterohemorrhagic E. coli in Austria. Pediatr Infect Dis J. 2001;20:316–318.
Miller B, Kassenborg H, Dunsmuir W, Griffith J, Hadidi M, Nordin JD, et al. Syndromic surveillance for influenzalike illness in ambulatory care network. Emerg Infect Dis. 2004;10:1806–1811.
Author information
Authors and Affiliations
Corresponding author
Additional information
1These authors contributed equally to this work.
The authors identify serious public health crises in Japan over the last 50 years (environmental pollution, food-borne diseases, and health hazards due to pharmaceuticals), and analyze commonalities. Lack of corporate ethics and ill-timed disclosure of information emerge as the principal problems, and the basis for their recommendations for corrective measures.
Rights and permissions
About this article
Cite this article
Imamura, T., Ide, H. & Yasunaga, H. History of Public Health Crises in Japan. J Public Health Pol 28, 221–237 (2007). https://doi.org/10.1057/palgrave.jphp.3200131
Published:
Issue Date:
DOI: https://doi.org/10.1057/palgrave.jphp.3200131